Fraunhofer Institute for Interfacial Engineering and Biotechnology IGBThe focus of the transnational collaboration project HyperIn, funded within the ERA-Net Program, lies in the integrated approach for the identification of novel P450-enzymes with the potential for targeted conversion of fine chemicals within industrial processes. Therefore, de-novo sequencing procedures of non-characterized bacteria and fungi followed by a functional annotation of the genomes, as well as identification of active genes via gene expression analyses, are some aspects of the project which are addressed by the Functional Genomics group.
ERA-HyPerIn
Project partners
- Heinrich-Heine-Universität Düsseldorf (Germany)
- Novartis Pharma AG (Switzerland)
- Synthetica As (Norway)
- University College London (Great-Britain)
- University of Warsaw (Poland)
- Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB (Germany)
- c-LEcta GmbH, Leipzig (Germany)
Funding
Research studies accounting for results in this project are funded according to the financial support agreement no. 035581 within the seventh framework program of the European Union (RP7/2007-2013).